Screening for Primary Aldosteronism in a Cohort of Brazilian Patients With Resistant Hypertension

被引:5
作者
Nogueira, Armando R. [1 ]
Bloch, Katia V. [2 ,3 ]
机构
[1] Univ Hosp Clementino Fraga Filho, Hypertens Program, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Community Hlth, Rio De Janeiro, Brazil
关键词
D O I
10.1111/j.1751-7176.2008.08421.x
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The objective was to estimate the prevalence of plasma aldosterone concentration:plasma renin activity ratio >30 ng/dL:ng/mL/h in patients with resistant hypertension and to describe the computed tomography findings of adrenal glands in those with elevated ratios. In a cross-sectional design, 492 patients were enrolled. All patients with plasma aldosterone concentration:plasma renin activity ratio >= 30 ng/dL:ng/mL/h (n=77) underwent abdominal computed tomography. Patients with an adrenal image of possible aldosterone-producing adenoma underwent a saline-loading test. The prevalence of elevated plasma aldosterone concentration:plasma renin activity ratio was 15.7% (95% confidence interval,12.6-19.2). Twelve patients showed adrenal abnormalities oil computed tomography. The level of renin was low in 50% of the sample. Results indicate a low Prevalence of aldosterone-producing adenoma. Our evidence points out the importance of confirming the hypothesis that essential hypertension, low-renin hypertension, and idiopathic hyperaldosteronism could be the same disease, but at different neurohormonal stages, and aldosterone-producing adenoma may be yet another disease. J Clin Hypertens (Greenwich). 2008;.10:619-623. (C) 2008 Le Jacq
引用
收藏
页码:619 / 623
页数:5
相关论文
共 20 条
[1]   Hyperaldosteronism among with resistant black and white subjects hypertension [J].
Calhoun, DA ;
Nishizaka, MK ;
Zaman, MA ;
Thakkar, RB ;
Weissmann, P .
HYPERTENSION, 2002, 40 (06) :892-896
[2]   Effect of spironolactone on blood pressure in subjects with resistant hypertension [J].
Chapman, Neil ;
Dobson, Joanna ;
Wilson, Sarah ;
Dahlof, Bjorn ;
Sever, Peter S. ;
Wedel, Hans ;
Poulter, Neil R. .
HYPERTENSION, 2007, 49 (04) :839-845
[3]   Aldosterone blockade: An emerging strategy for abrogating progressive renal disease [J].
Epstein, Murray .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (11) :912-919
[4]   A SCREENING-TEST TO IDENTIFY ALDOSTERONE-PRODUCING ADENOMA BY MEASURING PLASMA-RENIN ACTIVITY - RESULTS IN HYPERTENSIVE PATIENTS [J].
HIRAMATSU, K ;
YAMADA, T ;
YUKIMURA, Y ;
KOMIYA, I ;
ICHIKAWA, K ;
ISHIHARA, M ;
NAGATA, H ;
IZUMIYAMA, T .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (12) :1589-1593
[5]   Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing [J].
Hood, S ;
Cannon, J ;
Foo, R ;
Brown, M .
CLINICAL MEDICINE, 2005, 5 (01) :55-60
[6]   The current epidemic of primary aldosteronism: causes and consequences [J].
Kaplan, NM .
JOURNAL OF HYPERTENSION, 2004, 22 (05) :863-869
[7]   Potentially high prevalence of primary aldosteronism in a primary-care population [J].
Lim, PO ;
Rodgers, P ;
Cardale, K ;
Watson, AD ;
MacDonald, TM .
LANCET, 1999, 353 (9146) :40-40
[8]   The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? [J].
Lim, PO ;
Struthers, AD ;
MacDonald, TM .
JOURNAL OF HYPERTENSION, 2002, 20 (01) :11-15
[9]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[10]   Diagnosis of primary aldosteronism: from screening to subtype differentiation [J].
Mulatero, P ;
Dluhy, RG ;
Giacchetti, G ;
Boscaro, M ;
Veglio, F ;
Stewart, PM .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (03) :114-119